Service maintenance of N2 Generator

Added: Jun 22, 2016 12:21 pm

Solicitation:
HHSNIHOPC16013561

THIS IS NOT A REQUEST FOR PROPOSALS (RFP) OR A REQUEST FOR QUOTATIONS
(RFQ); NO CONTRACT WILL BE AWARDED PURSUANT TO THIS ANNOUNCEMENT.

This synopsis is for information and planning purposes only and is not to be construed as a
Commitment by the government. This is NOT a Request for Proposal, Invitation for Bid, or an
Announcement of a solicitation. Response to this Sources Sought is strictly voluntary and will
Not affect any firms' ability to submit an offer if a solicitation is released. There is no bid
Package or solicitation document associated with this announcement. The purpose of this
Document is to identify potential sources. Any requests for a solicitation package will be
Disregarded. The Government does not intend to award a contract on the basis of this source
Sought or otherwise pay for the information solicited. No entitlement to payment of direct or
Indirect costs or charges by the Government will arise as a result of preparing submissions in
Response to this sources sought and the Government's use of such information.
This Sources Sought is conducted to identify all potential sources capable of meeting the
Requirements described in the Performance Capabilities below:

Required Performance Capabilities:
Service maintenance for N2 Generator
• The immunopathogenesis of septic shock
• Studies of immune cellular function in respiratory distress syndrome, asthma, and other forms of severe pulmonary disease
• Biomarkers and novel therapies in pulmonary arterial hypertension
• Biomarkers of acute cellular rejection in heart transplantation
• Diagnosis and treatment of opportunistic infections
• Studies of immune cellular function and therapy of AIDS
• Pathogenesis and treatment of anthrax
• Emerging infectious diseases
• Biology and clinical effects of nitric oxide
o acute lung injury
o pulmonary arterial hypertension
o role as transcription regulatory factor
• Functional genomics of critical illness
o human acute inflammation
o animal model of septic shock and multiple organ failure
o pulmonary arterial hypertension
o solid organ transplantation
o Emerging Infectious Disease
o Pneumocystic

Interested Offerors should clearly submit Capability Statement and Business Information.

CAPABILITY STATEMENT -
• Status of the Company - Small manufacturer, Large Manufacturer, or Authorized
reseller of the Brand Name /Or Equal Equipment;
• Country of Origin of End Products - Domestic or Foreign;
BUSINESS INFORMATION -
• Company
• Company Name (including point of contact, phone number and email address)